Understanding and addressing geographic barriers to accessing TB services in a high-burden urban setting
Project Number5R01AI168424-02
Former Number1R01AI168424-01
Contact PI/Project LeaderJENKINS, HELEN E. Other PIs
Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
SUMMARY
Each year, over 10 million people become sick with tuberculosis (TB), and around 1.4 million die from the
disease. Around 86% of people with TB live in middle-income countries, with a large proportion living in cities.
To substantially decrease the global burden of TB, it is necessary to ensure that people are diagnosed quickly
and treated successfully. Geographic barriers to accessing health services – such as living far from a health
center – can lead to poor health outcomes. However, there is limited knowledge about how geographic access
barriers impact TB diagnosis and treatment outcomes in middle-income country urban settings. Health facilities
are generally present in these settings, but people with TB, who are often socially and economically
disadvantaged, face barriers in accessing them. We also lack tools for designing and targeting interventions
that address access barriers and thus improve TB diagnosis and treatment. This proposal seeks to address
these knowledge gaps using the “5 A’s” conceptual framework, which describes five domains that drive health
care access: availability, accessibility, accommodation, affordability, acceptability. To help understand how
geographic accessibility barriers and other types of access barriers contribute to delayed TB diagnosis, we will
apply structural equation modeling and simulation methods to data from TB patient surveys based on the 5 A’s
framework. To help programs target interventions to communities that are most at risk for delayed TB
diagnosis and incomplete TB treatment, we will create community-level risk scores that incorporate measures
of geographic accessibility as well as socioeconomic and demographic census data. To help programs develop
effective treatment support interventions, we will conduct a discrete choice experiment to identify optimal
packages of interventions aimed at addressing different types of access barriers during treatment, assessing
how preferences differ among different demographic groups. This proposal is significant because the results
will help TB programs to identify interventions that would be most effective for improving TB diagnosis and
treatment, and target these interventions to the individuals and communities that need them most. This
proposal is innovative because prior quantitative TB research studies have not used a health care access
conceptual framework, structural equation modeling or conjoint analysis to understand how to address access
barriers, or community risk scores to target interventions. In the long term, this research will help TB programs
reduce delays to diagnosis and incomplete treatment rates, thus reducing the global burden of TB morbidity
and mortality.
Public Health Relevance Statement
NARRATIVE
This study seeks to understand how geographic barriers to accessing tuberculosis services affect diagnostic
delay and incomplete treatment in middle-income country urban settings. It also explores how tuberculosis
programs can improve diagnosis and treatment by helping individuals and communities overcome access
barriers.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAffectAreaAwardCatchment AreaCause of DeathCensusesCharacteristicsCitiesCommunicable DiseasesCommunitiesCountryDataDiagnosisDiagnosticDiagnostic ServicesDiseaseEmployment StatusEquationEvidence based treatmentFaceGeographyGoalsHealthHealth Services AccessibilityHealth care facilityIncidenceIncomeIndividualInterventionKnowledgeMeasuresMethodsModelingMorbidity - disease rateNational Institute of Allergy and Infectious DiseaseNetwork-basedOutcomeParticipantPatientsPersonsPeruResearchResearch PriorityRiskSamplingServicesSurveysSymptomsTimeTravelTreatment outcomeTuberculosisTuberculosis diagnosisUnited States National Institutes of HealthVisitdesigneconomic disparityeconomic indicatoreffective therapyexperimental studygeographic barrierhealth care availabilityhigh riskimprovedinnovationmodels and simulationmortalitypoor health outcomepreferencepreventprogramsresearch studysexsimulationsocial disparitiessocioeconomicssurveillance datatherapy designtooltransmission processtuberculosis diagnosticstuberculosis treatmenturban setting
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
604483045
UEI
FBYMGMHW4X95
Project Start Date
01-February-2023
Project End Date
31-January-2028
Budget Start Date
01-February-2024
Budget End Date
31-January-2025
Project Funding Information for 2024
Total Funding
$572,061
Direct Costs
$469,619
Indirect Costs
$102,442
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$572,061
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI168424-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI168424-02
Patents
No Patents information available for 5R01AI168424-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI168424-02
Clinical Studies
No Clinical Studies information available for 5R01AI168424-02
News and More
Related News Releases
No news release information available for 5R01AI168424-02
History
No Historical information available for 5R01AI168424-02
Similar Projects
No Similar Projects information available for 5R01AI168424-02